<DOC>
	<DOCNO>NCT00155233</DOCNO>
	<brief_summary>1 . Nalbuphine opioid mu receptor antagonist kappa receptor agonist 2 . This study design investigate interaction nalbuphine morphine</brief_summary>
	<brief_title>Interaction Between Nalbuphine Morphine PCA</brief_title>
	<detailed_description>1 . Nalbuphine opioid mu receptor antagonist kappa receptor agonist 2 . This study design investigate interaction nalbuphine morphine 3 . The analgesic effect opioid-related side effect investigate</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Nalbuphine</mesh_term>
	<criteria>1 . Age 1865 y/o 2 . Female patient ASA physical status I III 3 . Scheduled elective abdominal hysterectomy , myomectomy , excision ovarian tumor 1 . Patients definite diagnosis chronic pain syndrome , psychiatric disorder , drug abuse ( include opioids , NSAIDs , sedatives , antidepressant ) 2 . Intraoperative fentanyl use &gt; 3 Î¼g/kg 3 . Patients definite diagnosis esophageal reflux syndrome 4 . Use sedatives , antiemetic , antipruritic within 24 hour operation 5 . Surgery &gt; 4 hour laparoscopy surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>analgeisa</keyword>
	<keyword>postoperatve</keyword>
	<keyword>side effect</keyword>
</DOC>